Showing 681-690 of 20873 results for "".
- City of Hope Research Reveals an Immune Cell That Can Attack Cancerhttps://reachmd.com/news/city-of-hope-research-reveals-an-immune-cell-that-can-attack-cancer/2456837/According to preclinical research published online today in Cell, one of the world’s premier scientific journals, researchers at City of Hope® have discovered that a type of immune cell in the human bo
- Tirzepatide Linked to Lower 1-Year MACE Risk in T2Dhttps://reachmd.com/news/tirzepatide-linked-to-lower-1-year-mace-risk-in-t2d/2488173/Key Takeaways In US adults with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide initiation was associated with a lower 1-year risk of major adverse cardiovascular events than sitagliptin. The absolute 1-year major adverse cardiovas
- GLP-1 Receptor Agonists and Psoriasis: What the Primer Reportshttps://reachmd.com/news/glp-1-receptor-agonists-and-psoriasis-what-the-primer-reports/2487937/Key Takeaways GLP-1 receptor agonists were associated with lower psoriasis severity and parallel quality-of-life gains in the studies summarized by the primer. Improvement was reported most often among patients with obesity or type 2 diabetes, while the unde
- Analysis: Biologics Linked to Lower Cardiometabolic Risk in HShttps://reachmd.com/news/analysis-biologics-linked-to-lower-cardiometabolic-risk-in-hs/2485805/Biologics were associated with a lower incidence of type 2 diabetes mellitus (T2DM) and cardiovascular events vs. no biologic use in a TriNetX cohort of 291,283 patients with hidradenitis suppurativa (HS), according to a new study in the Journal of Drugs in Dermatology. Investigat
- Study: Tirzepatide Shows Early Efficacy in Hidradenitis Suppurativahttps://reachmd.com/news/study-tirzepatide-shows-early-efficacy-in-hidradenitis-suppurativa/2484716/New research shows dual GLP-1/GIP inhibitor tirzepatide, a dual GLP-1/GIP receptor agonist currently approved for type 2 diabetes and obesity, may offer a novel therapeutic option for patients with moderate-to-severe hidradenitis suppurativa (HS), according to a sm
- Semaglutide Shows Promise in Alleviating Obesity-Related Knee Painhttps://reachmd.com/news/semaglutide-shows-promise-in-alleviating-obesity-related-knee-pain/2468693/Knee osteoarthritis, a debilitating condition linked to obesity, could soon have a new treatment option on the horizon. A phase 3 clinical trial has revealed that semaglutide—a drug already recognized for managing type 2 diabetes and promoting weight loss—may significantly reduce knee pain and im
- Looking to Boost Your Heart Health? Try a Baked Potatohttps://reachmd.com/news/looking-to-boost-your-heart-health-try-a-baked-potato/2467754/The potato is small enough to fit inside a person’s hand yet contains enough nutrients to whittle waistlines and lower blood sugar in adults with Type 2 diabetes. Yet, despite the fact that potatoes – particularly the skins – are packed with health-boosting
- Scientists Link Certain Gut Bacteria to Lower Heart Disease Riskhttps://reachmd.com/news/scientists-link-certain-gut-bacteria-to-lower-heart-disease-risk/2462561/Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affec
- Overcoming Tumor Recurrence: Advancements in Cancer Immunotherapyhttps://reachmd.com/news/overcoming-tumor-recurrence-advancements-in-cancer-immunotherapy/2475268/Persistent tumor recurrence is a significant challenge in oncology, with recurrence rates varying by cancer type. These
- Non-Culturable Legionella Identified with Sequencinghttps://reachmd.com/news/non-culturable-legionella-identified-with-sequencing/2462412/Legionella pneumophila. Credit: public domain Legionnaires' disease (LD), a rare and severe type of pneumonia, is a resp